IDXX heads into Q1 earnings with strong growth forecasts, steady estimate beats, and momentum in diagnostics and recurring ...
Shares of IDEXX Laboratories IDXX have rallied 39.1% over the past 12 months, showing impressive momentum. The stock has outpaced its industry, which rose 2.3%, as well as the S&P 500 Composite’s 29.6 ...